|
2025
|
Invention
|
Chimeric bocavirus capsid proteins. The present invention provides chimeric bocavirus capsid prot... |
|
|
Invention
|
Novel bocavirus capsid peptide insertion sites. The present invention provides recombinant bocavi... |
|
|
Invention
|
Retinal cell 3d culture. The present invention relates to methods for obtaining a retinal progeni... |
|
|
Invention
|
Modulators of the integrated stress response pathway.
The present invention relates to compounds... |
|
|
Invention
|
Nlrp3 modulators. The present invention relates to compounds or a pharmaceutically acceptable sal... |
|
2024
|
Invention
|
Rho-associated protein kinase inhibitors. The present disclosure provides compounds of the formul... |
|
|
Invention
|
Plasmids, transgenes, vectors and medical uses comprising tissue non-specific alkaline phosphatas... |
|
|
Invention
|
Nlrp3 modulators. The present invention relates to compounds of formula (I) or an isotopic labele... |
|
|
Invention
|
Antibodies binding to cd2, and multifunctional molecules comprising such antibodies. The present ... |
|
|
Invention
|
Cystobactamid derivatives. The present invention relates to novel cystobactamid derivatives of fo... |
|
|
Invention
|
7 inhibitors. 4747477 inhibtors in the treatment of diseases or conditions associated to inflamma... |
|
|
Invention
|
Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatit... |
|
|
Invention
|
New odilorhabdins analogues as antibiotics against multi-resistant bacteria. P. aeruginosaP. aeru... |
|
2023
|
Invention
|
Interferon-associated antigen binding proteins for use for the treatment or prevention of influen... |
|
|
Invention
|
Interferon-associated antigen binding proteins for use for the treatment or prevention of parainf... |
|
|
Invention
|
Interferon-associated antigen binding proteins for use for the treatment or prevention of respira... |
|
|
Invention
|
New cell populations and means and methods for their differentiation and preservation.
The inven... |
|
|
Invention
|
New cell populations and means and methods for their differentiation and preservation. The invent... |
|
|
Invention
|
Assay for drug discovery based on in vitro differentiated cells.
Provided are assay systems for ... |
|
|
Invention
|
Interferon-associated antigen binding proteins and uses thereof. The present invention relates to... |
|
2022
|
Invention
|
Interferon-associated antigen binding proteins for use for the treatment or prevention of coronav... |
|
2021
|
Invention
|
Modulators of the integrated stress response pathway. The present invention relates to compounds ... |
|
|
Invention
|
Modulators of the integrated stress response pathway. 2 have the meaning as indicated in the desc... |
|
2020
|
P/S
|
Pharmaceutical cost management services. Medical and scientific research; conducting clinical tri... |
|
|
P/S
|
Pharmaceutical cost management services.
Medical and scientific research in the fields of neurosc... |
|
|
P/S
|
Pharmaceutical cost management services Medical and scientific research in the fields of neurosci... |
|
|
Invention
|
Interferon-associated antigen binding proteins for use in treating hepatitis b infection. The pre... |
|
|
Invention
|
Non-invasive, in vitro functional tissue assay systems. Provided are functional cell and tissue a... |
|
|
P/S
|
Chemicals for scientific, medical and industrial research purposes, in particular cells, cell cul... |
|
|
P/S
|
Chemical products for scientific and industrial purposes, In particular cells, cell cultures and ... |
|
2019
|
Invention
|
Pyrazolopyrimidine compounds as adenosine receptor antagonists. The invention provides a compound... |
|
|
Invention
|
Combination therapy for treating hepatitis b virus infection.
The invention relates to methods o... |
|
2018
|
Invention
|
Non-invasive, in vitro functional tissue assay systems.
Provided are functional cell contacts fo... |
|
2017
|
Invention
|
Derivatives of 2-amino-4-(2-oxazolidinon-3-yl)-pyrimidine fused with a five-membered heteroaromat... |
|
2016
|
Invention
|
Inhibitors of bacterial glycosyl transferases.
Described herein are compounds of Formula (I′), F... |
|
|
Invention
|
Inhibitors of bacterial glycosyl transferases. Described herein are compounds of Formula (I'), Fo... |
|
|
Invention
|
Tissue modeling in embryonic stem (es) cell system.
Provided are embryonic stem (ES) cell-derive... |
|
2015
|
Invention
|
Sulfoximine substituted quinazolines for pharmaceutical compositions. The application relates to ... |
|
|
P/S
|
[ A collection of microorganisms, pathogens; a collection of bacteria, fungi, protozoa and viruse... |
|
2014
|
P/S
|
Collection of microorganisms, pathogens; collection of bacteria, fungi, protozoa and viruses; col... |
|
2008
|
P/S
|
Pharmaceutical cost management services; medical and scientific research, namely, conducting clin... |
